BCAL Diagnostics Limited (ASX:BDX)
0.0690
0.00 (0.00%)
Jun 10, 2025, 4:10 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 25.25 million as of June 12, 2025. Its market cap has increased by 6.48% in one year.
Market Cap
25.25M
Enterprise Value
19.54M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 25.25M, a decrease of -51.17%. That is a compound annual growth rate of -16.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 10, 2025 | 25.25M | -28.87% |
Dec 31, 2024 | 35.50M | 42.50% |
Dec 29, 2023 | 24.91M | 96.37% |
Dec 29, 2022 | 12.69M | -50.95% |
Dec 29, 2021 | 25.87M | -49.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 118.21B |
Pro Medicus | 29.61B |
Cochlear | 17.63B |
Sonic Healthcare | 12.79B |
Telix Pharmaceuticals | 8.78B |
Ramsay Health Care | 8.55B |
Ansell | 4.52B |
Mesoblast | 2.38B |